Literature DB >> 10529184

Dihydroorotate dehydrogenase B of Enterococcus faecalis. Characterization and insights into chemical mechanism.

J Marcinkeviciene1, L M Tinney, K H Wang, M J Rogers, R A Copeland.   

Abstract

Enterococcus faecalis dihydroorotate dehydrogenase B is a heterodimer of 28 and 33 kDa encoded by the pyrK and pyrDb genes. Both subunits copurify during all chromatographic steps, and, as determined by HPLC, one FMN and one FAD are bound per heterodimer. The enzyme catalyzes efficient oxidation of 4-S-NADH by orotate. Isotope effect and pH data suggest that reduction of flavin by NADH at the PyrK site is only partially rate limiting with no kinetically significant proton transfer occurring in the reductive half-reaction; therefore, a group exhibiting a pK of 5.7 +/- 0.2 represents a residue involved in binding of NADH rather than in catalysis. The reducing equivalents are shuttled between the NADH-oxidizing flavin in PyrK and the orotate-reacting flavin in PyrDb, by iron-sulfur centers through flavin semiquinones as intermediates. A solvent kinetic isotope effect of 2.5 +/- 0.2 on V is indicative of rate-limiting protonation in the oxidative half-reaction and most likely reflects the interaction between the isoalloxazine N1 of the orotate-reducing flavin and Lys 168 (by analogy with L. lactis DHODase A). The oxidative half-reaction is facilitated by deprotonation of the group(s) with pK(s) of 5.8-6.3 and reflects either deprotonation of the reduced flavin or binding of orotate; this step is followed by hydride transfer to C6 and general acid-assisted protonation (pK of 9.1 +/- 0.2) at C5 of the product.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529184     DOI: 10.1021/bi990674q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

Authors:  Margaret A Phillips; Pradipsinh K Rathod
Journal:  Infect Disord Drug Targets       Date:  2010-06

2.  Untargeted LC-MS metabolomic studies of Asteraceae species to discover inhibitors of Leishmania major dihydroorotate dehydrogenase.

Authors:  Lucas A Chibli; Annylory L Rosa; Maria Cristina Nonato; Fernando B Da Costa
Journal:  Metabolomics       Date:  2019-04-04       Impact factor: 4.290

3.  The dimeric dihydroorotate dehydrogenase A from Lactococcus lactis dissociates reversibly into inactive monomers.

Authors:  Mette Brimheim Ottosen; Olof Björnberg; Sofie Nørager; Sine Larsen; Bruce Allan Palfey; Kaj Frank Jensen
Journal:  Protein Sci       Date:  2002-11       Impact factor: 6.725

4.  Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase.

Authors:  Nicholas A Malmquist; Ramesh Gujjar; Pradipsinh K Rathod; Margaret A Phillips
Journal:  Biochemistry       Date:  2008-01-29       Impact factor: 3.162

5.  b-type dihydroorotate dehydrogenase is purified as a H2O2-forming NADH oxidase from Bifidobacterium bifidum.

Authors:  Shinji Kawasaki; Takumi Satoh; Mitsunori Todoroki; Youichi Niimura
Journal:  Appl Environ Microbiol       Date:  2008-12-05       Impact factor: 4.792

6.  Identification of 3,4-Dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase.

Authors:  Endah Dwi Hartuti; Takaya Sakura; Mohammed S O Tagod; Eri Yoshida; Xinying Wang; Kota Mochizuki; Rajib Acharjee; Yuichi Matsuo; Fuyuki Tokumasu; Mihoko Mori; Danang Waluyo; Kazuro Shiomi; Tomoyoshi Nozaki; Shinjiro Hamano; Tomoo Shiba; Kiyoshi Kita; Daniel Ken Inaoka
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.